scispace - formally typeset
J

Jörg H. Leupold

Researcher at Heidelberg University

Publications -  27
Citations -  2779

Jörg H. Leupold is an academic researcher from Heidelberg University. The author has contributed to research in topics: Metastasis & Cancer. The author has an hindex of 15, co-authored 27 publications receiving 2537 citations. Previous affiliations of Jörg H. Leupold include Ludwig Maximilian University of Munich & German Cancer Research Center.

Papers
More filters
Journal ArticleDOI

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer.

TL;DR: This is the first study to show that Pdcd4 is negatively regulated by miR-21, and the first report to demonstrate that mi R-21 induces invasion/intravasation/metastasis.
Journal ArticleDOI

Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors

TL;DR: Data suggest Pdcd4 as a new negative regulator of intravasation, and qas the invasion-related gene u-PAR, the first study to implicate PdCD4 regulation of gene expression via Sp1/Sp3.
Journal ArticleDOI

MicroRNA Regulation of Epithelial to Mesenchymal Transition

TL;DR: This article dissects the contribution of microRNAs to EMT and analyzes the molecular basis for their roles in this cellular process, and emphasizes their interaction with core transcription factors like the zinc finger enhancer (E)-box binding homeobox), Snail and Twist families as well as some pluripotency transcription factors.
Journal ArticleDOI

MicroRNAs as novel targets and tools in cancer therapy

TL;DR: This review summarizes and discusses the latest findings on how mi RNAs have become therapeutic targets of diverse synthetic antagonists, how novel endogenous regulators of miRNAs such as ceRNAs or pseudogenes could emerge as therapeutics scavenging oncogenic miRNA-regulators and how miRNAAs themselves are already, and will increasingly be, used as therapeuers.